Published in Diabet Med on March 01, 1999
The threshold for diagnosing impaired fasting glucose: a position statement by the European Diabetes Epidemiology Group. Diabetologia (2006) 1.07
A screening procedure detecting high-yield candidates for OGTT. The Women's Health in the Lund Area (WHILA) study: a population based study of middle-aged Swedish women. Eur J Epidemiol (2001) 0.94
Associations between blood glucose and carotid intima-media thickness disappear after adjustment for shared risk factors: the KORA F4 study. PLoS One (2012) 0.89
Cardiovascular characteristics in subjects with increasing levels of abnormal glucose regulation: the Strong Heart Study. Diabetes Care (2012) 0.88
Impaired fasting glucose: Pro-diabetic, "atheroprotective" and modified by metabolic syndrome. World J Diabetes (2013) 0.78
Fasting but not postprandial (postmeal) glycemia predicts the risk of death in subjects with coronary artery disease. Can J Cardiol (2007) 0.78
Glucose intolerance: is it a risk factor for cardiovascular disease in children with chronic kidney disease? Pediatr Nephrol (2011) 0.77
Three years follow-up of screen-detected diabetic and non-diabetic subjects: who is better off? The ADDITION Netherlands study. BMC Fam Pract (2008) 0.76
Impact of cardiovascular risk factors on carotid intima-media thickness: sex differences. Clin Interv Aging (2016) 0.75
Cost-effectiveness analysis of voglibose for prevention of type 2 diabetes mellitus in Japanese patients with impaired glucose tolerance. J Diabetes Investig (2010) 0.75
Current therapeutic agents and anesthetic considerations for diabetes mellitus. Korean J Anesthesiol (2012) 0.75
Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem J (1998) 7.15
Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level. Diabetes Care (2000) 2.59
SOCS3 exerts its inhibitory function on interleukin-6 signal transduction through the SHP2 recruitment site of gp130. J Biol Chem (2000) 2.14
Expression of suppressors of cytokine signaling during liver regeneration. J Clin Invest (2001) 1.71
Phosphorylation events modulate the ability of interferon consensus sequence binding protein to interact with interferon regulatory factors and to bind DNA. J Biol Chem (1997) 1.70
Subclinical inflammation is strongly related to insulin resistance but not to impaired insulin secretion in a high risk population for diabetes. Metabolism (2002) 1.68
Increased serum procalcitonin in newborn infants without infection. Clin Chem (1998) 1.67
The zinc finger protein Gfi-1 can enhance STAT3 signaling by interacting with the STAT3 inhibitor PIAS3. EMBO J (2000) 1.67
The postprandial state and the risk of atherosclerosis. Diabet Med (1997) 1.47
Relationship between fasting plasma glucose, atherosclerosis risk factors and carotid intima media thickness in non-diabetic individuals. Diabetologia (1998) 1.47
LPS and TNFalpha induce SOCS3 mRNA and inhibit IL-6-induced activation of STAT3 in macrophages. FEBS Lett (1999) 1.46
Postprandial plasma glucose is an independent risk factor for increased carotid intima-media thickness in non-diabetic individuals. Atherosclerosis (1999) 1.40
[Prevalence of newly diagnosed type 2 diabetes, impaired glucose tolerance and abnormal fasting glucose in a high risk population. Data from the RIAD study using new diagnostic criteria for diabetes]. Dtsch Med Wochenschr (1999) 1.40
Interaction of mitochondrial targeting signals with acidic receptor domains along the protein import pathway: evidence for the 'acid chain' hypothesis. EMBO J (1998) 1.30
IRF-1 induced cell growth inhibition and interferon induction requires the activity of the protein kinase PKR. Oncogene (1995) 1.27
Identification of high- and low-risk patients before liver transplantation: a prospective cohort study of nutritional and metabolic parameters in 150 patients. Hepatology (1997) 1.24
Identification of mammalian cell clones exhibiting highly regulated expression from inducible promoters. Trends Genet (1995) 1.23
Interferon regulatory factor 1 (IRF-1) mediates cell growth inhibition by transactivation of downstream target genes. Nucleic Acids Res (1993) 1.21
Current progress and future challenges in the biochemical diagnosis and treatment of pheochromocytomas and paragangliomas. Horm Metab Res (2008) 1.17
Increased intimal-medial thickness in newly detected type 2 diabetes: risk factors. Diabetes Care (1999) 1.16
Mass spectrometric identification of proteins released from mitochondria undergoing permeability transition. Cell Death Differ (2000) 1.15
Immune adherence in renal glomeruli. Complement receptor sites on glomerular capillary epithelial cells. Am J Pathol (1977) 1.11
Different protein turnover of interleukin-6-type cytokine signalling components. Eur J Biochem (1999) 1.09
Cytoplasmic STAT proteins associate prior to activation. Biochem J (2000) 1.06
The inhibition of interleukin-6-dependent STAT activation by mitogen-activated protein kinases depends on tyrosine 759 in the cytoplasmic tail of glycoprotein 130. J Biol Chem (2000) 0.99
The cytoplasmic tyrosine motifs in full-length glycoprotein 130 have different roles in IL-6 signal transduction. J Immunol (2000) 0.99
A multifunctional vector family for gene expression in mammalian cells. Gene (1994) 0.99
The MKK6/p38 mitogen-activated protein kinase pathway is capable of inducing SOCS3 gene expression and inhibits IL-6-induced transcription. Biol Chem (2001) 0.98
Characterization and binding specificity of the monomeric STAT3-SH2 domain. J Biol Chem (1999) 0.98
Effect of targeting normal fasting glucose levels with basal insulin glargine on glycaemic variability and risk of hypoglycaemia: a randomized, controlled study in patients with early Type 2 diabetes. Diabet Med (2010) 0.96
Subclinical inflammation in newly detected Type II diabetes and impaired glucose tolerance. Diabetologia (2002) 0.96
Constitutive internalization and association with adaptor protein-2 of the interleukin-6 signal transducer gp130. FEBS Lett (1998) 0.93
Identification of a Leu-lle internalization motif within the cytoplasmic domain of the leukaemia inhibitory factor receptor. Biochem J (1999) 0.92
Impact of n-3 fatty acid supplemented parenteral nutrition on haemostasis patterns after major abdominal surgery. Br J Nutr (2002) 0.91
Studies on the interleukin-6-type cytokine signal transducer gp130 reveal a novel mechanism of receptor activation by monoclonal antibodies. J Biol Chem (2000) 0.91
Control of post-prandial hyperglycemia--an essential part of good diabetes treatment and prevention of cardiovascular complications. Nutr Metab Cardiovasc Dis (2002) 0.91
Clinical experiences with low-molecular weight heparins in pediatric patients. Thromb Res (2001) 0.90
A completely foreign receptor can mediate an interferon-gamma-like response. EMBO J (2001) 0.90
Effects of insulin glargine versus metformin on glycemic variability, microvascular and beta-cell function in early type 2 diabetes. Acta Diabetol (2013) 0.89
Procalcitonin as a marker for the early diagnosis of severe infection after thermal injury. J Burn Care Rehabil (1999) 0.89
Non-redundant signal transduction of interleukin-6-type cytokines. The adapter protein Shc is specifically recruited to rhe oncostatin M receptor. J Biol Chem (2000) 0.87
Regulation of cell growth by IRF-1 in BHK-21 cells. Cytotechnology (1996) 0.87
Influence of treatment with acarbose or glibenclamide on insulin sensitivity in type 2 diabetic patients. Diabetes Obes Metab (2003) 0.86
Coagulation markers predict survival in cancer patients. Thromb Haemost (2002) 0.86
Clinical importance of prothrombotic risk factors in pediatric patients with malignancy--impact of central venous lines. Eur J Pediatr (1999) 0.86
Alcohol consumption and other psycho-social conditions as important factors in the development of diabetic foot ulcers. Diabet Med (2011) 0.86
Childhood education: a review of effects on the woman and her family. Fam Community Health (1986) 0.84
Prevalence and atherosclerosis risk in different types of non-diabetic hyperglycemia. Is mild hyperglycemia an underestimated evil? Exp Clin Endocrinol Diabetes (2000) 0.84
Effect of increased protein intake and nutritional status on whole-body protein metabolism of AIDS patients with weight loss. Metabolism (1995) 0.84
Association between reduced human leukocyte antigen (HLA)-DR expression on blood monocytes and increased plasma level of interleukin-10 in patients with severe burns. Clin Chem Lab Med (1999) 0.83
Deep vein and isolated calf muscle vein thrombosis following long-haul flights: pilot study. Blood Coagul Fibrinolysis (2002) 0.83
European study on dose-response relationship of acarbose as a first-line drug in non-insulin-dependent diabetes mellitus: efficacy and safety of low and high doses. Acta Diabetol (1998) 0.83
[Intima-media thickness in healthy probands without risk factors for arteriosclerosis]. Dtsch Med Wochenschr (2001) 0.83
Effects of the alpha glucosidase inhibitor acarbose on endothelial function after a mixed meal in newly diagnosed type 2 diabetes. Horm Metab Res (2008) 0.83
A new peptide-affinity tag for the detection and affinity purification of recombinant proteins with a monoclonal antibody. J Immunol Methods (2000) 0.83
Plasma prostacyclin and thromboxane concentrations in 160 normotensive, hypotensive, and preeclamptic patients during pregnancy, delivery, and the post partum period. J Perinat Med (1993) 0.83
Evaluation of desmopressin effects on haemostasis in children with congenital bleeding disorders. Haemophilia (2008) 0.82
Signal transduction of IL-6, leukemia-inhibitory factor, and oncostatin M: structural receptor requirements for signal attenuation. J Immunol (2000) 0.82
The inhibitory effect of IL-1 beta on IL-6-induced alpha 2-macroglobulin expression is due to activation of NF-kappa B. J Immunol (2001) 0.82
In vivo formation of IRF-1 homodimers. Biochimie (1999) 0.81
2-Chloro-4-nitrophenyl-beta-D-maltoheptaoside: a new substrate for the determination of alpha-amylase in serum and urine. J Clin Chem Clin Biochem (1984) 0.81
Interleukin-6-induced proliferation of pre-B cells mediated by receptor complexes lacking the SHP2/SOCS3 recruitment sites revisited. Eur J Biochem (2001) 0.81
The histologic characteristics of primary and restenotic carotid plaque. J Surg Res (1998) 0.81
Platelet function in obese children and adolescents. Hamostaseologie (2010) 0.81
Relationship between HbA1c on target, risk of silent hypoglycemia and glycemic variability in patients with type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes (2011) 0.81
[Effect of peripheral venous parenteral feeding on the postoperative protein status]. Infusionsther Klin Ernahr (1979) 0.80
Significance of antibodies to cardiolipin in unselected patients with systemic lupus erythematosus: clinical and laboratory associations. The SLE Study Group. Rheumatol Int (1995) 0.80
Proliferation control of mammalian cells by the tumor suppressor IRF-1. Cytotechnology (1995) 0.80
Effects of salinomycin on human bone marrow-derived mesenchymal stem cells in vitro. Toxicol Lett (2013) 0.80
Effect of acarbose on postmeal mononuclear blood cell response in patients with early type 2 diabetes: the AI(I)DA study. Horm Metab Res (2009) 0.80
Structures and relative stability of medium-sized silicon clusters. V. Low-lying endohedral fullerenelike clusters Si31-Si40 and Si45. J Chem Phys (2006) 0.80
Differential inhibition of IL-6-type cytokine-induced STAT activation by PMA. FEBS Lett (2000) 0.79
Relation of free and specifically bound leptin to insulin secretion in patients with impaired glucose tolerance (IGT). Exp Clin Endocrinol Diabetes (1999) 0.79
Different effects of acarbose and glibenclamide on proinsulin and insulin profiles in people with Type 2 diabetes. Diabetes Res Clin Pract (2002) 0.79
Measurement of CEA, TPA, neopterin, CA125, CA153 and CA199 in sera of pregnant women, umbilical cord blood and amniotic fluid. Gynecol Obstet Invest (1989) 0.79